Robert Shafer
Robert Shafer
Professor of Medicine, Stanford University
Email verificata su stanford.edu - Home page
TitoloCitata daAnno
2011 update of the drug resistance mutations in HIV-1
VA Johnson, V Calvez, HF Gnthard, R Paredes, D Pillay, R Shafer, ...
Topics in antiviral medicine 19 (4), 156, 2011
11632011
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ...
PloS one 4 (3), 2009
8762009
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
TIHIVC Study
Science (New York, NY) 330 (6010), 1551, 2010
7802010
Human immunodeficiency virus reverse transcriptase and protease sequence database
SY Rhee, MJ Gonzales, R Kantor, BJ Betts, J Ravela, RW Shafer
Nucleic acids research 31 (1), 298-303, 2003
7622003
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection
PM Small, RW Shafer, PC Hopewell, SP Singh, MJ Murphy, E Desmond, ...
New England Journal of Medicine 328 (16), 1137-1144, 1993
7061993
2017 update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, HF Gnthard, VA Johnson, R Paredes, D Pillay, ...
Topics in antiviral medicine 24 (4), 132, 2016
5922016
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.
RW Shafer, LM Smeaton, GK Robbins, SW De Gruttola, Victor, Snyder, ...
New England Journal of Medicine 349 (24), 2304-15, 2003
557*2003
Web resources for HIV type 1 genotypic-resistance test interpretation
TF Liu, RW Shafer
Clinical infectious diseases 42 (11), 1608-1618, 2006
4892006
Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance
C Wang, Y Mitsuya, B Gharizadeh, M Ronaghi, RW Shafer
Genome research 17 (8), 1195-1201, 2007
4732007
HIV-1 drug resistance mutations: an updated framework for the second decade of HAART
RW Shafer, JM Schapiro
AIDS reviews 10 (2), 67, 2008
4002008
Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection.
RW Shafer, DS Kim, JP Weiss, JM Quale
Medicine 70 (6), 384-397, 1991
3871991
Genotypic testing for human immunodeficiency virus type 1 drug resistance
RW Shafer
Clinical microbiology reviews 15 (2), 247-277, 2002
3852002
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
RW Shafer, SY Rhee, D Pillay, V Miller, P Sandstrom, JM Schapiro, ...
Aids 21 (2), 215-223, 2007
3612007
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ...
PLoS medicine 2 (4), 2005
3562005
HIV-1 antiretroviral resistance
MW Tang, RW Shafer
Drugs 72 (9), e1-e25, 2012
3182012
Update of the drug resistance mutations in HIV-1: March 2013
VA Johnson, V Calvez, HF Gnthard, R Paredes, D Pillay, RW Shafer, ...
Topics in antiviral medicine 21 (1), 6, 2013
2972013
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.
AK Iversen, RW Shafer, K Wehrly, MA Winters, JI Mullins, B Chesebro, ...
Journal of virology 70 (2), 1086-1090, 1996
2971996
Rationale and uses of a public HIV drug‐resistance database
RW Shafer
The Journal of infectious diseases 194 (Supplement_1), S51-S58, 2006
2942006
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study
DW Haas, LM Smeaton, RW Shafer, GK Robbins, GD Morse, L Labb, ...
The Journal of infectious diseases 192 (11), 1931-1942, 2005
2852005
Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade
RW Shafer, BR Edlin
Clinical infectious diseases 22 (4), 683-704, 1996
2631996
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20